| 1 |
33524870 | Knockdown of PC4 increases chemosensitivity of Oxaliplatin in triple negative breast cancer by suppressing mTOR pathway. | 2021 Mar 12 |
1 |
| 2 |
33565716 | Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR-138-5p and activation of AKT/mTOR signaling pathway. | 2021 Feb |
1 |
| 3 |
33653494 | Oxaliplatin and Gedatolisib (PKI-587) Co-Loaded Hollow Polydopamine Nano-Shells with Simultaneous Upstream and Downstream Action to Re-Sensitize Drugs-Resistant Hepatocellular Carcinoma to Chemotherapy. | 2021 Jan 1 |
3 |
| 4 |
34017210 | MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway. | 2021 |
2 |
| 5 |
32818544 | GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway. | 2020 Nov 1 |
3 |
| 6 |
30468657 | Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K/Akt/MTOR pathway. | 2019 Jan 1 |
1 |
| 7 |
31497229 | PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway. | 2019 |
3 |
| 8 |
29587559 | Involvement of pro-inflammation signal pathway in inhibitory effects of rapamycin on oxaliplatin-induced neuropathic pain. | 2018 Jan-Dec |
2 |
| 9 |
27856287 | The inhibition of spinal synaptic plasticity mediated by activation of AMP-activated protein kinase signaling alleviates the acute pain induced by oxaliplatin. | 2017 Feb |
3 |
| 10 |
28060954 | Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis. | 2017 |
4 |
| 11 |
28463955 | Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway. | 2017 May 2 |
3 |
| 12 |
27565326 | Oxaliplatin-rapamycin combination was superior to mono-drug in treatment of hepatocellular carcinoma both in vitro and in vivo. | 2016 |
1 |
| 13 |
25777765 | Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells. | 2015 Jul |
1 |
| 14 |
21718595 | Protective autophagy antagonizes oxaliplatin-induced apoptosis in gastric cancer cells. | 2011 Jul |
1 |
| 15 |
19128511 | Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells. | 2009 Jan 8 |
3 |